Chris Taylor | Vice President, Investor Relations and Corporate Communications |
Laurence Cooper | Chief Executive Officer |
Satyavrat Shukla | Chief Financial Officer |
David Mauney | President |
Alethia Young | Cantor Fitzgerald |
David Novak | Raymond James |
Ramakanth Swayampakula | H.C. Wainwright & Co., LLC |
Thomas Flaten | Lake Street Capital Markets, LLC |
Yale Jen | Laidlaw & Company |
Greetings and welcome to the Ziopharm Oncology First Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Chris Taylor, Investor Relations at Ziopharm.